Catalysis of the reaction: inosine 5'-phosphate + NAD+ + H2O = xanthosine 5'-phosphate + NADH + H+.

Includes alpha- and beta-dystroglycan; alternative products of the same gene; the laminin-binding component of the dystrophin-associated glycoprotein complex, providing a link between the subsarcolemmal cytoskeleton (in muscle cells) and the extracellular matrix. alpha-dystroglycan is an extracellular protein binding to alpha-laminin and to beta-dystroglycan; beta-dystroglycan is a transmembrane protein which binds alpha-dystroglycan and dystrophin.

Catalysis of the reaction: L-iditol + NAD+ = L-sorbose + NADH + H+.

Formed of five N-glycosylated sarcoglycans: alpha-, beta-, gamma-, delta-, and epsilon sarcoglycan, single-pass transmembrane proteins that form a complex which is fixed to the dystrophin axis by a lateral association with the dystroglycan complex.

protein phosphatase type 4 regulator activity

protein phosphatase type 4, intrinsic regulator activity

Modulation of the activity of the enzyme protein phosphatase type 4.

Includes alpha-, beta1-, beta2-syntrophins and syntrophin-like proteins; the syntrophin complex binds to the second half of the carboxy-terminal domain of dystrophin; also associates with neuronal nitric oxide synthase.

That fraction of cells, prepared by disruptive biochemical methods, that includes the plasma and other membranes.

That fraction of cells, prepared by disruptive biochemical methods, that is soluble in water.

That fraction of cells, prepared by disruptive biochemical methods, that is not soluble in water.

Interacting selectively with cyclosporin A, a cyclic undecapeptide that contains several N-methylated and unusual amino acids.

Combining with interleukin-17 to initiate a change in cell activity.

Any process that generates a purine, any nucleobase, nucleoside, nucleotide or nucleic acid that contains a purine base, from derivatives of them without de novo synthesis.

Combining with a peptidoglycan to initiate a change in cell activity.

Combining with ICAM-3, intercellular adhesion molecule 3, to initiate a change in cell activity. ICAM-3, or CD50, are constitutively expressed on monocytes, granulocytes and lymphocytes; on physiological stimulation, they become transiently phosphorylated on serine residues.